Neutral impactOrders & Deals

Onyx Biotec Limited — ISD for Open Offer-Post Tendering Stage

NSE 8 hrs ago·17 Nov 2026, 1:17 pm
Onyx Biotec

Onyx Biotec has announced the completion of the tendering stage for its open offer. This means the company has received and processed the share purchase applications from shareholders who have accepted the offer price.

This development is a key milestone in the tender process. It brings the company closer to finalizing the acquisition of the targeted stake. The next step will involve the settlement of shares and the release of funds to the successful tenderers.

Investors should monitor the exchange filing for the final settlement details and the updated shareholding pattern. This information will confirm the exact number of shares tendered and the final outcome of the open offer.

Affected stocks

Neutral1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Onyx Biotec (ONYX).
  • Category: Orders & Deals.

Why it matters

A routine update for Onyx Biotec. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.